Low-cap oncology stocks: Small companies fighting cancer
17 symbolsUpdated
As knowledge of what causes and helps prevent cancer develops, so does the expertise on how to tackle it face-on. Today, oncology represents one of the world’s fastest-moving therapeutic areas, set to represent more than a quarter of pharmaceutical sales by 2022. Part of this growth has been facilitated by the emergence of smaller companies taking innovative and novel approaches to the clinical practices such as T-cell treatments and precision medicines.
This Spark contains some of these smaller firms involved in cancer research or treatment in the US, with a market cap of less than 300m. For bigger companies, we have you covered with major firms or mid-cap firms. But don't rely on these lists alone. This isn't advice, so make sure you do your own research.
News
No news today
Turns out there's no information yet on the latest world events
These giants of the drugs world were in focus during the global pandemic, but there's much more to this multi-billion dollar industry than just vaccines.